Apply Now Enquire Now

Dr. Amit Singh


Areas of Specialization: Pharmaceutics

Degrees Ph.D. from AKTU, UP and M. Pharm from Bundelkhand University, PGDPRA from Jamia Hamdard, and PDCTM From Rahe Life Sciences. 

Professional Experience

The Growth Path (Total experience: 16 Years)

Since Nov’18             Professor & Divisional Chair

Aug’17-Nov’18         Professor & Principal 

Jun’12-Sep’17            Associate Professor & Head (Department of Pharmaceutics)

Dec’11–Jun’12           Assistant Professor (Department of Pharmaceutics)

Sep’09–Dec’11           Senior Lecturer (Department of Pharmaceutics)

Jun’06–Sep’09            Lecturer (Department of Pharmaceutics)



  • Granted: 01
  • Published: 02
  • Under process: 07
  • Published Indian Patent (Reference no.  / Application no. 201611019323, TEMP / E12 / 213 / 2016 / DEL): Formulation of novel carrier systems (liposomes, niosomes & nanospheres) for the treatment of fungal.
  • Published Indian Patent (Reference no.  / Application no.  201612040093, TEMP / E1 / 39388 / 2016 / DEL): Development of liposomal formulation for fungal infections and methods thereof.
  • Published Indian Patent (Reference no. / Application no. 201612040094, TEMP / E1 / 39390 / 2016 / DEL): Formulation of novel niosomal carriers for treatment of fungal infections and methods thereof.




Major Publications

  • National: 04
  • International: 35


  • “Mesenchymal Stem Cell-Derived Extracellular Vesicles: Regenerative Potential and Challenges”. Biology, 2021, 10, 172. (Journal Citation Reports, Clarivate Analytics = 5.09)


  •  ‘Graphene-based nanomaterial system: a boon in the era of smart nanocarriers ’Journal of Pharmaceutical Investigation,2021, Feb, Springer Sciences (Journal Citation Reports, Clarivate Analytics = 3.22)


  •  “Development and Validation of Stability Indicating High Performance Liquid Chromatography Method for Related Substances of Imatinib Mesylate” Indian Journal of Pharmaceutical Sciences, 84(2): April-May, 2022, PP-465-476.


  • “Skin Diseases and their Treatment Strategies in Sub-Saharan African Regions”. Infectious Disorders - Drug Targets, Volume 22, Issue 2, 2022.


  •  “A Fully Validated UHPLC-MS/MS Method for Estimation of Pimavanserin in Human (K2EDTA) Plasma and its Application to a Clinical Pharmacokinetic Study”. J. of Chromatographic Science, 2021.


  •  “Method Development and Validation of a Novel UHPLC Coupled with MS/MS Method for the Estimation of Brivaracetam in Human (K2EDTA) Plasma Samples and its Application to Pharmacokinetic Study”. Current Pharmaceutical Analysis. 


  • , “Isolation of new phytometabolites from Alpinia galanga willd rhizomes” Pak. J. Pharm. Sci., Vol.34, No.4, July 2021, pp.1397-1401. 


Book/ Book chapters published:

Book Publication: 01

Book Chapters: 03 (Under review)

No. of UG student Guided: 20

No. of PG student Guided: 40

Ph.D. Guidance         : 04 (All)

                   (Ongoing): 02

      (Thesis submitted): 01

(Viva-voce conducted): 01


  • Completed 5-day faculty development programme (e-FDP) titled “Restructuring Pharmacy Education for Atmanirbhar Bharat: Time for Transformation” at Lloyd Institute of Management & Technology, Greater Noida on 20-24th July, 2020. 
  • Participated as delegates in webinar on “Preparation of Tablet and capsule in Pharmaceuticals” at G H Raisoni University on 25/07/2020. 


  • Participated as delegates in webinar on IAs on Inpods LMS-Teaching Training-9th July. 2020 at Galgotias University. 


  • Participated as delegates in international webinar on “Introduction to Peptide Delivery and Mind Training for Impactful Publication” on May 31, 2020 at Galgotias University. 


Awards & Honors

                        : TOP 2% Scientist selected for 2021 by Elsevier BV, Stanford University 

                 : Certificate of appreciation towards “Research & Innovation” for the calendar year  


                        : GATE qualified, AICTE Scholarship (PG)  

                        : PG level University 1St Rank holder

                        : PCI Panel member, Govt of India

                        : CPCAEA member, Govt of India

Professional Body Memberships

  • Appointed as ‘Expert Member’ by Panel of Pharmacy Council of India (PCI), New Delhi.  
  • Nominee for Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA).
  • Life Member of “The Association of Pharmaceutical Teachers, (APTI)” (UP / LM - 149, 3 / 09 / 2007).
  • Registered as “Life Associate Member of Indian Red Cross Society” (Reg. No. – 1616 – 11 / 07 / 2003).
  • “Registered Pharmacist” in Uttar Pradesh Pharmacy Council, 209, Arif Ashiana Complex, Chowk, Lucknow, India-226003.  (Reg. No. - 23149, 20 / 10 / 1999). 
  • Accorded with 1st rank‟ in M. Pharm., (Pharmaceutics) from Bundelkhand University, Jhansi, U.P. India in 2006.
  • Honoured with scholarship from All India Council for Technical Education AICTE, New Delhi, India in 2004 - 2006.

Field of Expertise: 

  • Nano particles-based drug delivery system
  • Targeted drug delivery /Cancer based drug dosage form development
  • Analytical method development expertise

Pre-clinical study experts